Author: Wiesenfeld-Hallin Z.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.55, Iss.1, 1998-01, pp. : 1-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Second Generation of COX-2 Inhibitors: What Advantages Do the Newest Offer?
By Stichtenoth D.O. Frölich J.C.
Drugs, Vol. 63, Iss. 1, 2003-01 ,pp. :
Aldosterone Receptor Antagonists for Hypertension: What Do They Offer?
Drugs, Vol. 63, Iss. 19, 2003-01 ,pp. :
COX-2 Selective Nonsteroidal Anti-Inflammatory Drugs: Do They Really Offer Any Advantages?
Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. :
Third-Generation Antidepressants: Do They Offer Advantages Over the SSRIs?
By Olver J.S. Burrows G.D. Norman T.R.
CNS Drugs, Vol. 15, Iss. 12, 2001-01 ,pp. :